Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001657312-25-000010
Filing Date
2025-02-27
Accepted
2025-02-27 08:46:22
Documents
82
Period of Report
2024-12-31

Document Format Files

Seq Description Document Type Size
1 10-K vrna-20241231.htm   iXBRL 10-K 1846359
2 EX-4.3 vrna-descriptionofsecuriti.htm EX-4.3 223385
3 EX-10.10 andrewfisher-veronaofferle.htm EX-10.10 31599
4 EX-10.19 verona-firstamendmenttorev.htm EX-10.19 140640
5 EX-19.1 verona-insidertradingcompl.htm EX-19.1 83335
6 EX-23.1 eyconsent.htm EX-23.1 3003
7 EX-23.2 pwcveronaconsent-updated26.htm EX-23.2 2141
8 EX-31.1 exhibit311q424.htm EX-31.1 8860
9 EX-31.2 exhibit312q424.htm EX-31.2 8955
10 EX-32.1 exhibit321q424.htm EX-32.1 5143
11 EX-32.2 exhibit322q424.htm EX-32.2 5300
17 GRAPHIC image_0.jpg GRAPHIC 288
18 GRAPHIC image_1.jpg GRAPHIC 1337
19 GRAPHIC image_2.jpg GRAPHIC 94946
20 GRAPHIC vrna-20241231_g1.jpg GRAPHIC 283393
21 GRAPHIC vrna-20241231_g2.jpg GRAPHIC 157409
22 GRAPHIC vrna-20241231_g3.jpg GRAPHIC 244388
23 GRAPHIC vrna-20241231_g4.gif GRAPHIC 8735
  Complete submission text file 0001657312-25-000010.txt   10292850

Data Files

Seq Description Document Type Size
12 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vrna-20241231.xsd EX-101.SCH 55561
13 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT vrna-20241231_cal.xml EX-101.CAL 78358
14 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT vrna-20241231_def.xml EX-101.DEF 229210
15 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vrna-20241231_lab.xml EX-101.LAB 741264
16 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vrna-20241231_pre.xml EX-101.PRE 486483
85 EXTRACTED XBRL INSTANCE DOCUMENT vrna-20241231_htm.xml XML 795811
Mailing Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE
Business Address 3 MORE LONDON RIVERSIDE LONDON X0 SE1 2RE 011-44-0-2032834200
Verona Pharma plc (Filer) CIK: 0001657312 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38067 | Film No.: 25673233
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)